HSP90 inhibition blocks ERBB3 and RET phosphorylation in myxoid/round cell liposarcoma and causes massive cell death in vitro and in vivo.
about
Advances in sarcoma diagnostics and treatmentThe Under-Appreciated Promiscuity of the Epidermal Growth Factor Receptor FamilyRecent translational research into targeted therapy for liposarcoma.High-Throughput Screening of Myxoid Liposarcoma Cell Lines: Survivin Is Essential for Tumor Growth.Kinase profiling of liposarcomas using RNAi and drug screening assays identified druggable targets.Combined BRAF and HSP90 Inhibition in Patients with Unresectable -Mutant Melanoma
P2860
HSP90 inhibition blocks ERBB3 and RET phosphorylation in myxoid/round cell liposarcoma and causes massive cell death in vitro and in vivo.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
HSP90 inhibition blocks ERBB3 ...... ll death in vitro and in vivo.
@ast
HSP90 inhibition blocks ERBB3 ...... ll death in vitro and in vivo.
@en
type
label
HSP90 inhibition blocks ERBB3 ...... ll death in vitro and in vivo.
@ast
HSP90 inhibition blocks ERBB3 ...... ll death in vitro and in vivo.
@en
prefLabel
HSP90 inhibition blocks ERBB3 ...... ll death in vitro and in vivo.
@ast
HSP90 inhibition blocks ERBB3 ...... ll death in vitro and in vivo.
@en
P2093
P2860
P50
P356
P1433
P1476
HSP90 inhibition blocks ERBB3 ...... ll death in vitro and in vivo.
@en
P2093
Alexandra Jauhiainen
Christoffer Vannas
Emma Jonasson
Eva Wessel Stratford
Göran Stenman
Henrik Fagman
Magnus Hansson
Mikael Eriksson
Pernilla Grundevik
Regine Schneider-Stock
P2860
P304
P356
10.18632/ONCOTARGET.6336
P407
P577
2015-11-16T00:00:00Z